Search

Displaying results 2231 - 2240 of 7059 in total
  1. Drug

    Ervogastat

    go.drugbank.com/drugs/DB21489
    Experimental

    Ervogastat is a small molecule drug. Ervogastat has a monoisotopic molecular weight of 407.16 Da.

  2. Drug

    Amelenodor

    go.drugbank.com/drugs/DB21563
    Experimental

    Amelenodor is a small molecule drug. Amelenodor has a monoisotopic molecular weight of 399.16 Da.

  3. Drug

    Vulolisib

    go.drugbank.com/drugs/DB21567
    Experimental

    Vulolisib is a small molecule drug. Vulolisib has a monoisotopic molecular weight of 423.12 Da.

  4. Drug

    Teprosulvose

    go.drugbank.com/drugs/DB21738
    Experimental

    Teprosulvose is a small molecule drug. Teprosulvose has a monoisotopic molecular weight of 568.33 Da.

  5. Drug

    Suvadronabinol

    go.drugbank.com/drugs/DB21741
    Experimental

    Suvadronabinol is a small molecule drug. Suvadronabinol has a monoisotopic molecular weight of 513.31 Da.

  6. Drug

    Neratinib

    go.drugbank.com/drugs/DB11828
    ApprovedInvestigational

    Neratinib was approved in July 2017 for use as an extended adjuvant therapy in Human Epidermal Growth Factor Receptor 2 (HER2) positive breast cancer. Approval was granted to Puma Biotechnology Inc. for the tradename Nerlynx. Neratinib i...

    Categories: Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
  7. Drug

    Chromic chloride

    go.drugbank.com/drugs/DB09129
    Approved

    Chromic chloride, for injection, is a sterile, nonpyrogenic solution intended for use as an additive to solutions for Total Parenteral Nutrition (TPN).

    Mixtures: One-A-day Advance Men's, Great Day/am Formula TabCategories: Compounds used in a research, industrial, or household setting
  8. Drug

    Respiratory syncytial virus vaccine, adjuvanted

    go.drugbank.com/drugs/DB17762
    ApprovedInvestigational

    [L46347] On May 3, 2023, it was approved by the FDA for immunization against lower respiratory tract disease (LRTD) as the first respiratory syncytial virus (RSV) vaccine approved in the United States

    Synonyms: RSVPreF3 OA, RSVPreF3 OA vaccine
  9. Drug

    Gilteritinib

    go.drugbank.com/drugs/DB12141
    ApprovedInvestigational

    Gilteritinib, also known as ASP2215, is a small molecule part of the FLT3 tyrosine kinase inhibitors that presented a greater selectivity and potency when compared with other agents from this group. … [A40044] Gilteritinib was developed by Astellas Pharma and FDA approved on November 28, 2018.

  10. Drug

    Retapamulin

    go.drugbank.com/drugs/DB01256
    Approved

    It was approved by the FDA in April 2007.